home symptom
checker
autoimmune
conditions
lab test
search
resources
& tools
community
Read Tamra's story & find out how IWGW came to be! read more

About IWGW
News & Articles
Contact Us
Disclaimer
Shop IWGW Merchandise
Shop My AStore for Wellness
My Zazzle Shop
Stop by the IWGW Blog
All proceeds from sales go to supporting the costs of running the IWGW site (hosting, advertising, etc).

 
Autoimmune Conditions

Scleroderma

Scleroderma is a rare group of progressive diseases that can attack the skin, connective tissues (muscles, etc.) and internal organs (known as the systemic form). This autoimmune diseases causes an overproduction of certain proteins such as collagen that cause the skin to thicken and harden, known as fibrosis. The skin may appear as glossy and tight. The word Scleroderma means "hard skin". Scleroderma is grouped with Connective Tissue Diseases since the skin and underlying tissues are the connective tissues that make up the framework of our bodies. It is often classified with the Mixed Connective Tissue disease when there is not yet enough evidence to diagnose a patient with Scleroderma yet they show signs and symptoms that are similar to Scleroderma as well as other Connective Tissue Diseases.

There are two main forms of Scleroderma, CREST or Limited Systemic Sclerosis and Diffuse Systemic Sclerosis.

CREST is an acronym for the main symptoms the Limited form of Scleroderma causes.

Calcinosis - this is an actual calcification of the skin itself
Raynaud's Phenomenon - seen in about 90% of the cases, Raynaud's causes a constriction of the blood vessels in the fingers and toes. Read more ...
Esophageal Dysfunction - difficulty swallowing, also termed as dysphagia
Sclerodactyly - thickening and tightening of the skin
Telangiactasias - when the small vessels near the surface of the skin dilate, they often mimic small spider veins, petechiae or angiomas

Even though CREST primarily is a skin disease, Pulmonary Hypertension can become a serious complication in CREST as well.

The second form of Scleroderma, Diffuse Systemic Sclerosis, is the progressive form of Scleroderma that can affect large areas of the skin as well as internal organ systems, most commonly the lungs, kidneys, esophagus and heart.

Diffuse Systemic Sclerosis can also form as what is called "Sine Scleroderma" which has minimal or no skin involvement, but does involve internal organ systems. Forms of Diffuse Systemic Sclerosis that may not involve internal organ systems, but do harshly affect the skin are known as Morphea and Linear Scleroderma.

Morphea involves isolated patches of hardened skin while Linear tends to manifest as lines of hardened skin that often affect the underlying muscle and bone. You can read more about Morphea here on IWGW.com.

Complications that can result from Scleroderma:

Heart - high blood pressure, irregular heartbeat and most severely an enlarged heart

Kidney - in it's severity can cause renal failure

Lung - shortness of breath, coughing, difficulty breathing, inflammation of the air sacs, pneumonia, and cancer

Digestive System - difficulty swallowing, acid reflux, sluggish intestines, diarrhea, weight loss and anemia (iron deficiency)

Skin and Joints - carpal tunnel syndrome is common, muscle weakness, joint pain and stiffness

 

Symptoms:

Abdominal bloating
Abdominal pain
Areas of skin darkening
Areas of skin lightening
Calcium deposits on bony areas
Chest pain
Cold feet
Cold hands
Color changes in feet
Color changes in hands
Constipation
Diarrhea
Difficulty breathing
Difficulty chewing
Difficulty swallowing
Dry cough
Elbow pain
Elbows frozen in flexed position
Fingers frozen in flexed position
Frequent heartburn
General joint pain and stiffness
Headaches
High blood pressure
Hoarse voice
Impotence
Itchy skin
Knee pain with stiffness
Loose teeth
Muscle weakness
Pain in the fingers
Shortness of breath
Shoulder pain
Skin appears taut and shiny
Skin lesions on fingertips
Small spider veins across chest, face, hands, lips or mouth
Thickening of fingertips
Unintentional Weight loss
Wrist pain
Wrists frozen in flexed position

 

Diagnosis:

Physical signs of the skin hardening and tightening, nail fold capillary changes (the skin that overlaps the base and sides of your fingernails and toenails), and blood tests are usually used to diagnose a patient with Scleroderma. However, in many cases, patients exhibit physical signs for quite some time before blood tests begin to show markers for the disease, making it difficult to confirm a diagnosis right away. It can also be hard to diagnose because of the wide variety of forms of Scleroderma and how the disease can vary from person to person. Scleroderma is a rare disease and many of the symptoms mimic other autoimmune diseases such as Lupus. In many cases, a Scleroderma patient may be diagnoses first with Mixed Connective Tissue disease until blood tests begin to show the positive markers needed to confirm a Scleroderma diagnosis.

Physicians may also use X-Rays, CT Scans or other imaging to look for signs of lung, heart, kidney or other organ involvement.

Blood tests may show:

Negative Anti-SS B
Positive Anti-Topoisomerase I Antibody
Elevated Aldolase
Negative Anti-SS A
Positive Anti-Centromere Antibody
Elevated Creatine Phosphokinase
Positive Anti-Nuclear Antibody
Elevated Erythrocyte Sedimentation Rate


Treatment:

There is no known cure for any forms of Scleroderma so treatment is aimed at symptom management and relief, and immunosuppressant to try and tame the immune system response causing the body to attack itself. Some of the immunosuppressants include methotrexate, cyclophosphamide, azathioprine and mycophenolate.

Other treatments include creams to try to soften areas of the skin and reduce inflammation as well.

Prognosis:

Prognosis depends of the form of Scleroderma the patient has. Over recent years, survival rates have increased due to new treatments and options thanks to research and studies.

Morphea has a better outlook than those with widespread skin and organ involvement. Age can also play a factor in the survival rate as studies have shown older men and women have a lower survival rate. Younger patients may live 20 - 50 years after diagnosis. In most severe cases (less than 10% of diffuse Scleroderma cases) may have a 50% chance of survival in 5 years.

 

 
 

Go Back